Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p20
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 20/30)
Character Range: 56525–60016

Quantity: 56; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14647
(b) omit from the column headed "Purposes": P14647
[126] Schedule 1, Part 1, entry for Ustekinumab in the form Injection 90 mg in 1 mL single use pre-filled syringe [Maximum Quantity: 1; Number of Repeats: 1]
(a) omit from the column headed "Circumstances": C14802
(b) omit from the column headed "Purposes": P14802
[127] Schedule 1, Part 2, omit entry for Acalabrutinib
[128] Schedule 1, Part 2, after entry for Glucose indicator-urine
insert:
Hypromellose with carbomer 980  Ocular lubricating gel 3 mg-2 mg per g, 10 g  Application to the eye  Genteal gel  AQ  1
Hypromellose with carbomer 980  Ocular lubricating gel 3 mg-2 mg per g, 10 g  Application to the eye  HPMC PAA     IQ  1

[129] Schedule 4, Part 1, omit entry for Circumstances Code "C9203"
[130] Schedule 4, Part 1, omit entry for Circumstances Code "C9207"
[131] Schedule 4, Part 1, omit entry for Circumstances Code "C9367"
[132] Schedule 4, Part 1, omit entry for Circumstances Code "C9468"
[133] Schedule 4, Part 1, omit entry for Circumstances Code "C9469"
[134] Schedule 4, Part 1, omit entry for Circumstances Code "C12588"
[135] Schedule 4, Part 1, omit entry for Circumstances Code "C12937"
[136] Schedule 4, Part 1, omit entry for Circumstances Code "C14390"
[137] Schedule 4, Part 1, omit entry for Circumstances Code "C14431"
[138] Schedule 4, Part 1, omit entry for Circumstances Code "C14647"
[139] Schedule 4, Part 1, omit entry for Circumstances Code "C14802"
[140] Schedule 4, Part 1, omit entry for Circumstances Code "C15038"
[141] Schedule 4, Part 1, omit entry for Circumstances Code "C15370"
[142] Schedule 4, Part 1, entry for Circumstances Code "C15560"
omit from the column headed "Listed Drug": Hypromellose with carbomer 980
[143] Schedule 4, Part 1, omit entry for Circumstances Code "C15640"
[144] Schedule 4, Part 1, entry for Circumstance Code "C16094"
omit entry for Circumstances Code "C16094" and substitute:
C16094  P16094  CN16094  Voriconazole  Serious fungal infections                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures
                                       Treatment and maintenance therapy
                                       The condition must be caused by Scedosporium species; OR
                                       The condition must be caused by Fusarium species.
                                       Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.

[145] Schedule 4, Part 1, entry for Circumstances Code "C16189"
omit entry for Circumstances Code "C16189" and substitute:
C16189  P16189  CN16189  Methylphenidate  Attention deficit hyperactivity disorder                                                                                                       Compliance with Authority Required procedures
                                          Patient must have demonstrated a response to immediate-release methylphenidate hydrochloride